Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
American Journal of Hematology
|
August 24, 2023
Teclistamab in patients with multiple myeloma and impaired renal function
Laura Joiner, Susan Bal, Kelly N Godby, et al.
American Journal of Hematology
|
January 4, 2021
New regimens and directions in the management of newly diagnosed multiple myeloma
Susan Bal, Smith Giri, Kelly N Godby, et al.
Leukemia & Lymphoma
|
September 28, 2022
Clinical implications of measurable residual disease assessment in multiple myeloma in the era of quadruplet therapy
Susan Bal, Timothy M Schmidt, Luciano J Costa, et al.
Transplantation and Cellular Therapy
|
September 19, 2020
Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy
Susan Bal, Luciano J Costa, Craig Sauter, et al.
British Journal of Haematology
|
January 17, 2023
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma
Luciano J Costa, Smith Giri, Susan Bal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 22, 2022
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
Sean Patrick Bliven, Lauren Shea, Susan Bal, et al.
The Neuroradiology Journal
|
December 10, 2014
Potential of F-18 PET/CT in the Detection of Leptomeningeal Metastasis
Ryan G Short, Susan Bal, John P German, et al.
British Journal of Haematology
|
October 20, 2025
Reversing the sequence: Efficacy of BCMA-directed therapy following progression on GPRC5D-directed therapies in relapsed multiple myeloma
Laura Joiner, Smith Giri, Gayathri Ravi, et al.
Blood Cancer Journal
|
November 15, 2023
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies
Susan Bal, Noel Estrada-Merly, Luciano J Costa, et al.
American Journal of Cancer Research
|
August 15, 2022
Multiple myeloma with t(11;14): unique biology and evolving landscape
Susan Bal, Shaji K Kumar, Rafael Fonseca, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
American Journal of Hematology
|
August 24, 2023
Teclistamab in patients with multiple myeloma and impaired renal function
Laura Joiner, Susan Bal, Kelly N Godby, et al.
American Journal of Hematology
|
January 4, 2021
New regimens and directions in the management of newly diagnosed multiple myeloma
Susan Bal, Smith Giri, Kelly N Godby, et al.
Leukemia & Lymphoma
|
September 28, 2022
Clinical implications of measurable residual disease assessment in multiple myeloma in the era of quadruplet therapy
Susan Bal, Timothy M Schmidt, Luciano J Costa, et al.
Transplantation and Cellular Therapy
|
September 19, 2020
Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy
Susan Bal, Luciano J Costa, Craig Sauter, et al.
British Journal of Haematology
|
January 17, 2023
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma
Luciano J Costa, Smith Giri, Susan Bal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 22, 2022
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
Sean Patrick Bliven, Lauren Shea, Susan Bal, et al.
The Neuroradiology Journal
|
December 10, 2014
Potential of F-18 PET/CT in the Detection of Leptomeningeal Metastasis
Ryan G Short, Susan Bal, John P German, et al.
British Journal of Haematology
|
October 20, 2025
Reversing the sequence: Efficacy of BCMA-directed therapy following progression on GPRC5D-directed therapies in relapsed multiple myeloma
Laura Joiner, Smith Giri, Gayathri Ravi, et al.
Blood Cancer Journal
|
November 15, 2023
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies
Susan Bal, Noel Estrada-Merly, Luciano J Costa, et al.
American Journal of Cancer Research
|
August 15, 2022
Multiple myeloma with t(11;14): unique biology and evolving landscape
Susan Bal, Shaji K Kumar, Rafael Fonseca, et al.
Page
of 7